Genetic diseases Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting genetic diseases clinical trials across 9 countries. Studies span Not Applicable, Phase 3. Top locations include Nashville, Tennessee, United States, Paris, France, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Genetic diseases Trials at a Glance

13 actively recruiting trials for genetic diseases are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Nashville, Paris, and Boston. Lead sponsors running genetic diseases studies include Assistance Publique - Hôpitaux de Paris, Chiesi Farmaceutici S.p.A., and Asociación Española para el Estudio del Hígado.

Browse genetic diseases trials by phase

About Genetic diseases Clinical Trials

Looking for clinical trials for Genetic diseases? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Genetic diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Genetic diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

Genetic diseasesFeverROSAH+4 more
National Human Genome Research Institute (NHGRI)5,000 enrolled5 locationsNCT00001373
Recruiting

Characterization and Contribution of Genome-wide DNA Methylation (DNA Methylation Episignatures) in Rare Diseases With Prenatal Onset

Congenital MalformationRare Fetal Genetic Diseases
Assistance Publique - Hôpitaux de Paris63 enrolled1 locationNCT06475651
Recruiting
Phase 3

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Beta-ThalassemiaSickle Cell DiseaseHematologic Diseases+4 more
Vertex Pharmaceuticals Incorporated26 enrolled6 locationsNCT05477563
Recruiting

PKP2-ACM Natural History Study

Genetic diseasesCardiomyopathiesCardiovascular Diseases+1 more
Rocket Pharmaceuticals Inc.36 enrolled3 locationsNCT06644742
Recruiting
Phase 3

A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis Bullosa

Skin DiseasesEpidermolysis BullosaConnective Tissue Disease+7 more
Chiesi Farmaceutici S.p.A.6 enrolled6 locationsNCT06917690
Recruiting

Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions

neurological diseaseGenetic diseasesAutoimmune Diseases+1 more
Imagine Institute1,000 enrolled1 locationNCT06235580
Recruiting

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

Genetic diseasesAllergyImmunology+1 more
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled9 locationsNCT06762002
Recruiting

Genetic and Metabolic Disease in Children

Genetic diseasesMetabolic Diseases
University of Texas Southwestern Medical Center1,550 enrolled1 locationNCT02650622
Recruiting
Not Applicable

Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases

Neurogenetic Diseases
University Hospital, Rouen95 enrolled1 locationNCT06955624
Recruiting
Not Applicable

Effect of Large Neutral Amino Acids in Adults With Classical Phenylketonuria

Brain DiseasesMetabolic DiseasePhenylketonurias+5 more
Rigshospitalet, Denmark30 enrolled2 locationsNCT06337864
Recruiting

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Primary Sclerosing Cholangitis (PSC)Primary Biliary Cholangitis (PBC)Hepatitis Autoimmune Disease+1 more
Asociación Española para el Estudio del Hígado5,000 enrolled1 locationNCT06767605
Recruiting

Rett Syndrome Registry

Genetic DiseaseNeurologic DisorderNervous System Diseases+7 more
International Rett Syndrome Foundation3,000 enrolled18 locationsNCT05432349
Recruiting
Not Applicable

Rady Children's Institute Genomic Biorepository

Genetic diseases
Rady Pediatric Genomics & Systems Medicine Institute102,000 enrolled1 locationNCT02917460